跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,679 条关于
“nicotinic α4β2 receptor”
全部
13,679
临床试验
7,318
药物
1,362
机构
30
资讯
4,969
9个月前
Suven Life Sciences Completes Phase 2b Enrollment for Novel Depression Drug Ropanicant Two Months Ahead of Schedule
去年
Suven Life Sciences' Ropanicant Shows Positive Phase 2a Results for Major Depressive Disorder
去年
FDA Approves Alpha Cognition's ZUNVEYL® for Mild-to-Moderate Alzheimer's Disease
2年前
FDA Approves Zunveyl (benzgalantamine) for Mild-to-Moderate Alzheimer's Disease
3个月前
Cholinergic Regulation of Neuroinflammation: Microglia, Immunometabolism, and Therapeutic Frontiers
去年
Neuphoria Advances Dual Clinical Programs with Merck Partnership Milestone and Phase 3 SAD Trial Progress
3年前
Real-World Study Affirms Palbociclib's Efficacy in Chinese HR+/HER2- Metastatic Breast Cancer Patients
11年前
Palbociclib Plus Letrozole Significantly Extends Progression-Free Survival in ER+ Breast Cancer
2个月前
Neuphoria Confirms Merger Talks with Scancell as UK Biotech Eyes Nasdaq Listing
10个月前
Neuphoria Therapeutics Receives $5.20 Per Share Acquisition Offer from Lynx1 Master Fund Following Phase III Trial Failure
第 1 页,共 497 页
上一页
下一页